Israel Diabetes Care Devices Market Analysis & Forecasts to 2012

Product Code GDA00187
Publication Date January 2009
Publisher GlobalData
Product Type Report
Pages 72
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Israel Diabetes Care Devices Market Analysis & Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Israel diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Israel

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in Israel.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in Israel.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Diabetes Care Devices
    • 3.2 Glucose Monitoring
      • 3.2.1 Blood Glucose Meter
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Pen
      • 3.3.2 Insulin Pump
      • 3.3.3 Insulin Syringes
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Sector Review
    • 4.2 Healthcare Expenditure
  • 5 Regulation System
    • 5.1 Regulatory System
    • 5.2 Registration
    • 5.3 Standards
    • 5.4 Customs Duties
    • 5.5 Labeling
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 Diabetes Care Devices In Israel
    • 8.1 Diabetes Care Devices Cross Country Comparison (2000-2012)
    • 8.2 Diabetes Care Devices, Israel, Overall Revenue ($ mn), 2000-2012
    • 8.3 Diabetes Care Devices, Israel, Category Volume (Units), 2000-2012
    • 8.4 Diabetes Care Devices, Israel Company share (2006-2007)
  • 9 Glucose Monitoring In Israel
    • 9.1 Glucose Monitoring Overall Revenue (2000-2012)
    • 9.2 Glucose Monitoring Overall Volume (2000-2012)
    • 9.3 Glucose Monitoring Average Price (2000-2012)
    • 9.4 Glucose Monitoring Distribution Share (2006-2007)
    • 9.5 Glucose Monitoring, Israel, Company Share (2006-2007)
  • 10 Insulin Delivery In Israel
    • 10.1 Insulin Delivery Overall Revenue (2000-2012)
    • 10.2 Insulin Delivery Overall Volume (2000-2012)
    • 10.3 Insulin Delivery Average Price (2000-2012)
    • 10.4 Insulin Delivery Distribution Share (2006-2007)
    • 10.5 Insulin Delivery, Israel, Company Share (2006-2007)
  • 11 Diabetes Care Devices Market Trend Analysis
    • 11.1 Market Drivers
      • 11.1.1 High disease incidence
      • 11.1.2 Positive Trial Results
      • 11.1.3 Favorable Reimbursement
      • 11.1.4 Emerging Segments
      • 11.1.5 Focus on Research and Development (R&D) and Technological Development
    • 11.2 Market Restraints
      • 11.2.1 Pharmaceutical based treatment
      • 11.2.2 Competitive Technology
  • 12 Overview of Key Companies in Israel Diabetes Care Devices Market
    • 12.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 12.1.1 Company Overview
      • 12.1.2 Value Chain Analysis
      • 12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
      • 12.1.4 F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area
    • 12.2 LifeScan, Inc. Company Profile
      • 12.2.1 Company Overview
      • 12.2.2 LifeScan, Inc. Pipeline Products
    • 12.3 Bayer HealthCare AG Company Profile
      • 12.3.1 Company Overview
      • 12.3.2 Value Chain Analysis
      • 12.3.3 Bayer HealthCare AG Pipeline Products
    • 12.4 Abbott Laboratories Company Profile
      • 12.4.1 Company Overview
      • 12.4.2 Value Chain Analysis
      • 12.4.3 Abbott Laboratories Pipeline Products
    • 12.5 Novo Nordisk A/S Company Profile
      • 12.5.1 Company Overview
      • 12.5.2 Novo Nordisk A/S Pipeline Products
    • 12.6 Eli Lilly and Company Company Profile
      • 12.6.1 Company Overview
      • 12.6.2 Value Chain Analysis
      • 12.6.3 Eli Lilly and Company Pipeline Products
    • 12.7 Beta-O2 Technologies Ltd. Company Profile
      • 12.7.1 Company Overview
      • 12.7.2 Beta-O2 Technologies Ltd. Pipeline Products
    • 12.8 Medingo Ltd. Company Profile
      • 12.8.1 Company Overview
      • 12.8.2 Medingo Ltd. Pipeline Products
    • 12.9 NiliMEDIX Ltd. Company Profile
      • 12.9.1 Company Overview
      • 12.9.2 NiliMEDIX Ltd. Pipeline Products
    • 12.10 Integrity Applications Ltd
      • 12.10.1 Company Overview
    • 12.11 OrSense Ltd
      • 12.11.1 Company Overview
    • 12.12 G-Sense Ltd
      • 12.12.1 Company Overview
  • 13 Appendix
    • 13.1 Globaldata Research Methodology
    • 13.2 Coverage
    • 13.3 Secondary Research
    • 13.4 Primary Research
    • 13.5 Models
    • 13.6 Forecasts
    • 13.7 Expert Panels Validation
    • 13.8 Currency Conversion
    • 13.9 Contact Us
    • 13.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), (2000-2012)
    • Table 2: Diabetes Care Devices, Israel, Overall Revenue ($ mn), 2000-2012
    • Table 3: Diabetes Care Devices, Israel, Cross Segment Analysis, 2000-2012
    • Table 4: Diabetes Care Devices, Israel, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 5: Diabetes Care Devices, Israel, Overall Revenue ($ mn), Forecast, 2007-2012
    • Table 6: Diabetes Care Devices, Israel, Category Volume (Units), 2000-2012
    • Table 7: Diabetes Care Devices, Israel, Category Volume (Units), Historic, 2000-2007
    • Table 8: Diabetes Care Devices, Israel, Category Volume (Units), Forecast, 2007-2012
    • Table 9: Diabetes Care Devices, Israel Company share by Revenue ($ mn), 2006-2007
    • Table 10: Glucose Monitoring, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 11: Glucose Monitoring, Israel, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 12: Glucose Monitoring, Israel, Overall Volume (Units), Historic, 2000-2007
    • Table 13: Glucose Monitoring, Israel, Overall Volume (Units), Forecast, 2007-2012
    • Table 14: Glucose Monitoring, Israel, Average Price ($), Historic, 2000-2007
    • Table 15: Glucose Monitoring, Israel, Average Price ($), Forecast, 2007-2012
    • Table 16: Glucose Monitoring, Israel, Distribution Share by Revenue ($mn), 2006-2007
    • Table 17: Glucose Monitoring, Israel, Company Share by Revenue ($ mn), 2006-2007
    • Table 18: Insulin Delivery, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 19: Insulin Delivery, Israel, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 20: Insulin Delivery, Israel, Overall Volume (Units), Historic, 2000-2007
    • Table 21: Insulin Delivery, Israel, Overall Volume (Units), Forecast, 2007-2012
    • Table 22: Insulin Delivery, Israel, Average Price ($), Historic, 2000-2007
    • Table 23: Insulin Delivery, Israel, Average Price ($), Forecast, 2007-2012
    • Table 24: Insulin Delivery, Israel, Distribution Share by Revenue ($mn), 2006-2007
    • Table 25: Insulin Delivery, Israel, Company Share by Revenue ($ mn), 2006-2007
    • Table 26: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 27: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
    • Table 28: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area
    • Table 29: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 30: LifeScan, Inc. Pipeline Products by Development Stage
    • Table 31: LifeScan, Inc. Pipeline Products By Therapy Area
    • Table 32: LifeScan, Inc. Pipeline Products By Clinical Trials
    • Table 33: LifeScan, Inc. Pipeline Products By News Summaries
    • Table 34: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 35: Bayer HealthCare AG Pipeline Products By Development Stage
    • Table 36: Bayer HealthCare AG Pipeline Products By Therapy Area
    • Table 37: Bayer HealthCare AG Pipeline Products By News Summaries
    • Table 38: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 39: Abbott Laboratories Pipeline Products By Development Stage
    • Table 40: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 41: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 42: Abbott Laboratories Pipeline Products By News Summaries
    • Table 43: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 44: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 45: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 46: Novo Nordisk A/S Pipeline Products By Clinical Trials
    • Table 47: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 48: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 49: Eli Lilly and Company Pipeline Products By Therapy Area
    • Table 50: Eli Lilly and Company Pipeline Products By Clinical Trials
    • Table 51: Beta-O2 Technologies Ltd. Pipeline Products by Equipment Type
    • Table 52: Beta-O2 Technologies Ltd. Pipeline Products by Development Stage
    • Table 53: Beta-O2 Technologies Ltd. Pipeline Products By Therapy Area
    • Table 54: Medingo Ltd. Pipeline Products by Equipment Type
    • Table 55: Medingo Ltd. Pipeline Products by Development Stage
    • Table 56: Medingo Ltd. Pipeline Products By Therapy Area
    • Table 57: NiliMEDIX Ltd. Pipeline Products by Equipment Type
    • Table 58: NiliMEDIX Ltd. Pipeline Products By Development Stage
    • Table 59: NiliMEDIX Ltd. Pipeline Products By Therapy Area
    • Table 60: NiliMEDIX Ltd. Pipeline Products By Clinical Trials
    • Table 61: NiliMEDIX Ltd. Pipeline Products By News Summaries
    • Table 62: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • 1.2 List of Figures
    • Figure 1: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), (2000-2012)
    • Figure 2: Diabetes Care Devices, Israel, Overall Revenue ($ mn), 2000-2012
    • Figure 3: Diabetes Care Devices, Israel, Cross Segment Analysis, 2000-2012
    • Figure 4: Diabetes Care Devices, Israel, Overall Revenue ($ mn), Historic, 2000-2007
    • Figure 5: Diabetes Care Devices, Israel, Overall Revenue ($ mn), Forecast, 2007-2012
    • Figure 6: Diabetes Care Devices, Israel, Category Volume (Units), 2000-2012
    • Figure 7: Diabetes Care Devices, Israel, Category Volume (Units), Historic, 2000-2007
    • Figure 8: Diabetes Care Devices, Israel, Category Volume (Units), Forecast, 2007-2012
    • Figure 9: Diabetes Care Devices, Israel Company share (%), 2007
    • Figure 10: Glucose Monitoring, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 11: Glucose Monitoring, Israel, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 12: Glucose Monitoring, Israel, Overall Volume (Units), Historic, 2000-2007
    • Figure 13: Glucose Monitoring, Israel, Overall Volume (Units), Forecast, 2007-2012
    • Figure 14: Glucose Monitoring, Israel, Company Share (%), 2007
    • Figure 15: Insulin Delivery, Israel, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 16: Insulin Delivery, Israel, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 17: Insulin Delivery, Israel, Company Share (%), 2007
    • Figure 18: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 19: Bayer HealthCare AG Value Chain Analysis
    • Figure 20: Abbott Laboratories Value Chain Analysis
    • Figure 21: Eli Lilly and Company Value Chain Analysis
    • Figure 22: Globaldata Methodology